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Serological testing is a useful noninvasive method for
the diagnosis of Helicobacter pylori infection. It is easy
for patients to accept the test because of its noninvasive-
ness, and the results can be quickly obtained. Further-
more, this assay is a global test that evaluates the entire
stomach. Therefore, potential sampling errors can be
avoided.1
Many serological kits for H. pylori detection are
commercially available in clinical practice. The sensi-
tivity of enzyme-linked immunosorbent assay (ELISA)-
based serological tests ranges between 90% and 97%,
and the specificity ranges between 50% and 96%.2–4 The
sensitivity and specificity of serological tests mainly de-
pend on the nature of the antigenic materials used. In
addition to the antigens used, the presence of atrophic
gastritis is also one of the important factors that influ-
ence the test’s accuracy.
In the July 2010 issue of the Journal of the Chinese
Medical Association, Hung et al5 reported that a quan-
titative ELISA test (HEL-pTEST II; AMRAD, Kew,
VIC, Australia) had a decreased specificity for the
detection of H. pylori in patients with atrophic gastri-
tis (86.7% vs. 91.9% in patients with and without atro-
phic gastritis, respectively). However, this test was highly
sensitive for the detection of H. pylori infection in
patients with atrophic gastritis (100.0% vs. 96.5% in pa-
tients with and without atrophic gastritis, respectively).
Hung et al therefore concluded that a quantitative
ELISA test is suitable for the diagnosis of H. pylori infec-
tion in patients with atrophic gastritis because of its
excellent sensitivity.
In patients with atrophic gastritis, all invasive and
noninvasive tests for the diagnosis of H. pylori infection
have their restrictions because the bacterial load of 
H. pylori decreases gradually during the progression
of gastric atrophy, and bacteria are unevenly distri-
buted in the stomach. In cases with extensive intes-
tinal metaplasia, H. pylori can disappear completely.6
If H. pylori infection is patchy or if the number of bac-
teria is low, invasive diagnostic tests based on gastric
biopsies can yield inaccurate results because of sam-
pling errors.
Recently, Yoo et al7 confirmed that invasive H. pylori
tests, especially the CLO test, have a low detection rate
for H. pylori in the presence of mucosal atrophy and
intestinal metaplasia. Kokkola et al8 also demonstrated
that urease tests and histology have decreased sensi-
tivity for detection of H. pylori in patients with atrophic
gastritis. Furthermore, Korstanje et al9 showed that the
noninvasive 13C-urea breath test has decreased accuracy
for diagnosis of H. pylori infection in patients with
atrophic gastritis.
Shin et al,10 who recently evaluated the validity of
biopsy-based tests (histology, culture, and urease test)
and serological tests for detection of H. pylori infec-
tion, also reported a decreased specificity of serological
tests for the diagnosis of H. pylori infection in patients
with atrophic gastritis. When their analysis was limited
to patients without atrophic gastritis or intestinal meta-
plasia, all tests, except for culture, showed sensitivity
and specificity > 90%. However, the sensitivity of the
CLO test markedly decreased with the progression of
atrophic gastritis and intestinal metaplasia, and the sero-
logical test was markedly less specific in the presence of
atrophic gastritis (specificity, 40.7% vs. 83.7% in patients
with and without atrophic gastritis, respectively). The
authors suggested that a combination of at least 2
tests is necessary for the detection of H. pylori in 
the clinical settings of atrophic gastritis or intestinal
metaplasia.
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Hung et al5 reported that the results of ELISA
were indeterminate in 12.4% (21/170) of their patients.
They excluded these cases in the final analysis, but
such high uncertainty will influence the application of
serological tests as diagnostic or screening tools. A
“gray zone” result is a significant limitation of sero-
logical tests. H. pylori infection induces mucosal inflam-
mation in the stomach. Infected patients have shown
a wide variety of systemic antibody responses, thereby
leading to several indeterminate results in serological
tests.1 In cases with indeterminate results, other tests
should be performed to determine the status of 
H. pylori infection.
In addition, the accuracy of serological tests might
vary between different races and geographic regions,
possibly due to different antigenic properties of local
bacterial strains and antibodies of commercial kits used
for the diagnosis of H. pylori infection. The usefulness
of a serological assay should be assessed in a local setting.
In conclusion, the sensitivity of biopsy-based tests for
the diagnosis of H. pylori infection decreases with the
progression of atrophic gastritis. Quantitative ELISA is
a noninvasive and sensitive test for detection of H. pylori
infection in subjects with atrophic gastritis, but this
test is less specific in the presence of atrophic gastritis.
A combination of at least 2 tests (e.g. serology plus urea
breath test) is necessary in clinical practice to diagnose
H. pylori infection accurately in patients with atrophic
gastritis or intestinal metaplasia. If discordant results
of the tests exist, another sensitive test (e.g. histology)
can be performed to determine the status of H. pylori.
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